Skip to main content
. 2017 Nov 7;36:87. doi: 10.1186/s40880-017-0256-x

Fig. 1.

Fig. 1

Kaplan–Meier disease-free survival and Epstein–Barr virus (EBV) failure-free survival curves for the 385 patients with nasopharyngeal carcinoma who were treated with intensity-modulated radiotherapy